Health Care & Life Sciences » Pharmaceuticals | KYORIN Holdings Inc.

KYORIN Holdings Inc.

KYORIN Holdings Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY104.68
Market Cap
JPY112.91 B
Shares Outstanding
64.61 M
Public Float
35.91 M

Profile

Address
Ochanomizu Sola City, 16/F
Tokyo Tokyo 101
Japan
Employees -
Website http://www.kyorin-gr.co.jp
Updated 07/08/2019
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. It operates through the following segments: Pharmaceutical Business and Healthcare Business. The Pharmaceutical Business segment engages in the production and sales of prescription drugs, generic drugs, and over the counter drugs.

Financials

View All
Created with Highcharts 5.0.14KYORIN Holdings Inc.Net Income. Fiscal year is April-March. All values JPY Millions.12 02512 02512 06412 06413 63913 6397 3057 3056 5746 5746 8696 86920142015201620172018201902.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14KYORIN Holdings Inc.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.111 400111 400113 121113 121119 483119 483115 373115 373110 640110 640113 620113 620201420152016201720182019025k50k75k100k125k150k

Masahiro Yamashita
Chairman
Minoru Hogawa
President & Representative Director